Late Breaking Abstract - High blood neutrophils are associated with increased exacerbations and mortality in Chronic Obstructive Pulmonary Disease

M. Lonergan (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), M. Crichton (Dundee, United Kingdom), C. Fong (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), A. Cassidy (Dundee, United Kingdom), M. Van Dyke (Collegeville, United States of America), H. Mullerova (Uxbridge, United Kingdom), B. Miller (Collegeville, United States of America), R. Tal-Singer (Collegeville, United States of America), J. Chalmers (Dundee, United Kingdom)

Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Session: COPD clinical studies: bronchodilators, corticosteroids and more
Session type: Poster Discussion
Number: 3371
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Lonergan (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), M. Crichton (Dundee, United Kingdom), C. Fong (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), A. Cassidy (Dundee, United Kingdom), M. Van Dyke (Collegeville, United States of America), H. Mullerova (Uxbridge, United Kingdom), B. Miller (Collegeville, United States of America), R. Tal-Singer (Collegeville, United States of America), J. Chalmers (Dundee, United Kingdom). Late Breaking Abstract - High blood neutrophils are associated with increased exacerbations and mortality in Chronic Obstructive Pulmonary Disease. 3371

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of eosinopenia in predicting mortality and morbidity in patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019


Low Level of  Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Predictive factors for readmission of patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020



Effectiveness of pulmonary rehabilitation initiated after exacerbation of Chronic Obstructive Pulmonary Disease
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018

Pathogenic bacteria for exacerbation of Chronic Obstructive Pulmonary Disease
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018

Distribution of body water in hospitalized patients with Chronic Obstructive Pulmonary Disease and Right Heart Failure.
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019


Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD)
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020

Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) - is it a separate entity?
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018

“Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018

Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Association of Metabolic Syndrome with the severity of Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020


Metabolic paralysis in systemic immune cells of Chronic Obstructive Pulmonary Disease (COPD) subjects.
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018


Assessment of lung function in symptomatic and asymptomatic smokers without Chronic Obstructive Pulmonary Disease (COPD) using the Impulse Oscillatory Technique (IOT)
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020


Effects of a self-management program in exacerbated Chronic Obstructive Pulmonary Disease
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

Chronic Obstructive Pulmonary Disease Due to Biomass Smoke or Tobacco as risk factor to cachexia.
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019

The Impact of Multimorbidity on Hospitalizations in Patients with Chronic Obstructive Pulmonary Disease (COPD): a Population-Based Study
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019


Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir Rev 2009; 18: 133
Year: 2009


Adaptive capacities and complexity of heart rate variability in patients with Chronic Obstructive Pulmonary Disease throughout pulmonary rehabilitation
Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions
Year: 2021


Could Monocyte /HDL cholesterol ratio predict cardiovascular events in patients with Chronic Obstructive Pulmonary Disease ?
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017


Factors Associated With 90-day Readmission in Inpatients with Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Management of chronic lung conditions
Year: 2020